| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 48 | 62 | 71 | 93 | 112 | 138 | 180 | 222 | 311 | 283 | 287 | 282 |
| Expenses | 46 | 61 | 67 | 87 | 108 | 131 | 170 | 198 | 287 | 279 | 276 | 273 |
| EBITDA | 2 | 1 | 4 | 6 | 4 | 7 | 9 | 25 | 24 | 4 | 11 | 9 |
| Operating Profit % | 2 % | 2 % | 5 % | 6 % | 3 % | 5 % | 5 % | 11 % | 8 % | 1 % | 4 % | 3 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 1 | 0 | 3 | 5 | 2 | 6 | 7 | 24 | 23 | 3 | 10 | 7 |
| Tax | 0 | 0 | 1 | 2 | 1 | 2 | 2 | 6 | 6 | 0 | 3 | 2 |
| Net Profit | 0 | 0 | 2 | 3 | 2 | 4 | 5 | 17 | 17 | 2 | 7 | 5 |
| EPS in ₹ | 1.02 | 0.97 | 5.68 | 10.41 | 4.97 | 13.71 | 17.26 | 55.62 | 53.83 | 7.00 | 23.02 | 15.60 |
Samrat Pharmachem
Samrat Pharmachem
304.90
-2.65
(-0.86%)
Key Fundamentals
Market Cap
95.00 Cr
EPS
23.02
PE Ratio
19.56
Dividend Yield
0.33 %
Industry
Healthcare 52 Week High
550.00
52 Week Low
285.10
PB Ratio
1.31
Debt to Equity
0.13
Sector
Pharmaceuticals Actual
Company News
View All News
Samrat Pharmachem Shareholders Approve Re. 1 Per Share Dividend for FY 2024-25Sep 27, 2025
Samrat Pharmachem Limited shareholders approved a dividend of Re. 1 per share (10%) for financial year 2024-25 at the company's 33rd Annual General Meeting held on September 25, 2025. The meeting was conducted through video conferencing and other audio-visual means. The dividend applies to equity shares of Rs. 10 each.
Samrat Pharmachem Reports 30% Revenue Drop and Lower Profits in Q1 FY2026Aug 19, 2025
Samrat Pharmachem Limited reported declining financial performance with total income from operations falling to Rs. 101.72 crore in Q1 FY2026 from Rs. 144.86 crore in Q1 FY2025. Net profit decreased to Rs. 9.30 crore from Rs. 11.50 crore year-over-year, while earnings per share dropped to Rs. 7.89 from Rs. 9.76. Operating income declined significantly to Rs. 81.80 crore from Rs. 127.91 crore, though other income increased to Rs. 19.92 crore from Rs. 16.95 crore. The company faced higher costs with material consumption rising to Rs. 58.15 crore from Rs. 46.85 crore and employee benefit expenses increasing to Rs. 8.07 crore from Rs. 6.96 crore.
Samrat Pharmachem Reports Loss of Rs 22.89 Lakhs in Q1 FY26Aug 13, 2025
Samrat Pharmachem Limited reported a net loss of Rs 22.89 lakhs for the quarter ended June 30, 2025, compared to a profit of Rs 206.55 lakhs in the same quarter last year. Revenue from operations declined to Rs 7,565.16 lakhs from Rs 8,082.40 lakhs year-over-year. The company's cost of materials consumed increased significantly to Rs 8,251.71 lakhs compared to Rs 7,815.54 lakhs in the previous year. Basic and diluted earnings per share stood at negative Rs 0.74. The pharmaceutical chemicals manufacturer's board meeting was held on August 13, 2025, where the unaudited standalone financial results were approved and submitted to BSE.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,679.10 | #1 3,98,049.70 | 38.75 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 61.71 | |
6,621.50 | 1,75,222.50 | 76.19 | 9,712.00 | 18.67 | 2,191 | 26.74 | 72.60 | |
1,577.60 | 1,26,768.90 | 23.67 | 28,409.50 | 7.12 | 5,291 | 9.88 | 60.63 | |
3,584.30 | 1,19,599.80 | 60.49 | 11,539.40 | 6.99 | 1,911 | 19.91 | 53.74 | |
1,255.90 | 1,03,508.80 | #1 18.25 | 33,741.20 | 16.73 | 5,725 | 1.26 | 48.97 | |
2,476.60 | 1,01,344.60 | 53.48 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 47.04 | |
987.65 | 99,073.80 | 21.09 | 23,511.00 | 18.55 | 4,615 | 2.60 | 45.37 | |
1,940.00 | 89,121.90 | 23.79 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.82 | |
5,581.50 | 66,047.70 | 28.61 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.11 | |
1,101.00 | 64,254.10 | 19.04 | 32,345.60 | 9.43 | 3,484 | -10.24 | 50.87 |
Growth Rate
Revenue Growth
1.34 %
Net Income Growth
222.73 %
Cash Flow Change
-207.23 %
ROE
197.60 %
ROCE
199.19 %
EBITDA Margin (Avg.)
187.50 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 26 | 36 | 36 | 41 | 40 | 58 | 57 | 85 | 117 | 122 | 122 |
| Fixed Assets | 7 | 7 | 7 | 7 | 7 | 7 | 9 | 10 | 11 | 11 | 11 |
| Current Assets | 19 | 28 | 28 | 33 | 33 | 50 | 47 | 71 | 99 | 103 | 103 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 4 |
| Other Assets | 19 | 27 | 29 | 34 | 33 | 50 | 48 | 75 | 104 | 108 | 107 |
| Total Liabilities | 26 | 36 | 36 | 41 | 40 | 58 | 57 | 85 | 117 | 122 | 122 |
| Current Liabilities | 12 | 21 | 19 | 21 | 19 | 34 | 27 | 37 | 53 | 56 | 50 |
| Non Current Liabilities | 1 | 2 | 2 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| Total Equity | 14 | 14 | 15 | 19 | 20 | 24 | 30 | 47 | 63 | 65 | 72 |
| Reserve & Surplus | 10 | 11 | 12 | 15 | 17 | 21 | 27 | 44 | 60 | 62 | 69 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | -0 | -1 | -1 | 1 | -1 | 0 | 15 | -3 | -2 | -10 |
| Investing Activities | 0 | -2 | 1 | -2 | 2 | -2 | -3 | -1 | -3 | -0 | 0 |
| Operating Activities | -1 | -0 | -3 | 0 | 2 | -1 | 5 | 18 | -9 | 9 | -10 |
| Financing Activities | 0 | 2 | 1 | 2 | -4 | 2 | -2 | -2 | 10 | -11 | 1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 49.30 % | 49.30 % | 49.30 % | 49.65 % | 49.65 % | 49.65 % | 49.54 % | 48.64 % | 48.64 % | 48.64 % | 48.64 % | 48.64 % | 48.64 % | 48.64 % | 48.95 % | 49.09 % | 49.09 % | 49.09 % | 49.09 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 3.24 % | 3.24 % | 3.24 % | 3.24 % | 3.24 % | 0.00 % | 3.24 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.22 % | 0.22 % | 0.22 % | 0.00 % | 0.00 % | 3.24 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 42.44 % | 42.93 % | 42.96 % | 41.06 % | 37.41 % | 36.70 % | 37.09 % | 37.89 % | 38.48 % | 38.81 % | 42.58 % | 42.61 % | 41.69 % | 40.79 % | 41.34 % | 41.95 % | 41.58 % | 41.64 % | 41.73 % |
| Others | 8.26 % | 7.77 % | 7.74 % | 9.29 % | 12.95 % | 13.65 % | 13.37 % | 13.47 % | 12.88 % | 12.55 % | 8.78 % | 8.75 % | 6.22 % | 7.11 % | 6.25 % | 5.72 % | 6.09 % | 6.04 % | 5.95 % |
| No of Share Holders | 2,885 | 5,189 | 5,214 | 4,846 | 4,675 | 4,768 | 7,390 | 8,040 | 8,039 | 7,938 | 8,445 | 8,065 | 7,478 | 7,169 | 6,984 | 6,844 | 6,785 | 6,752 | 6,699 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 1 | 1 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 | 0.3 | 0.32 | 0.33 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 Nov 2025 |  Quarterly Result Announcement | NA | 14 Nov 2025 | 316.50 | 304.90 |
| 23 Sept 2022 |  Dividend | ₹ 1.00 /share | 22 Sept 2022 | 422.90 | 1,108.00 |
| 18 Sept 2023 | Dividend | ₹ 1.00 /share | 18 Sept 2023 | 491.50 | 399.85 |
| 19 Sept 2024 | Dividend | ₹ 1.00 /share | 19 Sept 2024 | 358.05 | 630.90 |
| 26 Sept 2024 |  Annual General Meeting | NA | 26 Sept 2024 | 358.05 | 530.25 |
| 14 Nov 2024 | Quarterly Result Announcement | NA | 14 Nov 2024 | 556.75 | 465.95 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 387.00 | 350.30 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 320.95 | 400.85 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 341.30 | 343.60 |
| 18 Sept 2025 | Dividend | ₹ 1.00 /share | 18 Sept 2025 | 400.85 | 326.65 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 400.85 | 317.60 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
9 days ago
9 days agoCorporate Action-Board approves DividendSep 27, 2025
Sep 27, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Sep 27, 2025Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended September 30 2025Sep 26, 2025
Sep 26, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Reg. 34 (1) Annual Report.Sep 04, 2025
Sep 04, 2025Book Closure: Friday September 19 2025 To Thursday September 25 2025 (Both Days Inclusive)Sep 04, 2025
Sep 04, 2025Record Date - Thursday September 18 2025Sep 04, 2025
Sep 04, 2025Notice Of 33Rd Annual General Meeting Of Samrat Pharmachem Limited On Thursday September 25 2025Sep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Aug 19, 2025Un-Audited Financial Results For The Quarter Ended June 30 2025Aug 13, 2025
Aug 13, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 25, 2025
Jul 25, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 16, 2025
Jul 16, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 01, 2025
Jul 01, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AJun 26, 2025
Jun 26, 2025Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 30-06-2025Jun 23, 2025
Jun 23, 2025Closure of Trading WindowJun 23, 2025
Jun 23, 2025Announcement under Regulation 30 (LODR)-Credit RatingJun 03, 2025
Jun 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 03, 2025
Jun 03, 2025Audited Financial Results For The Year Ended March 31 2025May 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of Board Meeting Held TodayMay 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Board Meeting Intimation for Notice Of Board Meeting For Approval Of Audited Financial Results For The Financial Year Ended March 31 2025Mar 26, 2025
Mar 26, 2025Closure of Trading WindowMar 20, 2025
Mar 20, 2025Integrated Filing (Financial)Mar 04, 2025
Mar 04, 2025General Announcement-Outcome Of Board Meeting (14-02-2025)Feb 14, 2025
Feb 14, 2025Outcome Of The Board Meeting Held Today - 14-02-2024Feb 14, 2025
Feb 14, 2025Approval Of Un-Audited Financial Results For The Quarter Ended December 31 2024Feb 14, 2025
Feb 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Held TodayFeb 14, 2025
Feb 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Jan 13, 2025Announcement under Regulation 30 (LODR)-Change in RTAJan 13, 2025
Jan 13, 2025Closure of Trading WindowDec 31, 2024
Dec 31, 2024Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31 2024Dec 31, 2024
Dec 31, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 21, 2024
Nov 21, 2024Un-Audited Financial Results For The Quarter Ended September 30, 2024Nov 14, 2024
Nov 14, 2024Board Meeting Outcome for Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024Nov 14, 2024
Nov 14, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 18, 2024
Oct 18, 2024Closure of Trading WindowSep 27, 2024
Sep 27, 2024Board Meeting Intimation for Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024Sep 27, 2024
Sep 27, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Sep 27, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2024
Sep 26, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2024
Sep 06, 2024Book ClosureSep 04, 2024
Sep 04, 2024Record Date: Thursday, September 19, 2024Sep 04, 2024
Sep 04, 2024Reg. 34 (1) Annual Report.Sep 04, 2024
Sep 04, 202432Nd Annual General Meeting On Thursday, September 26, 2024Sep 04, 2024
Sep 04, 2024Technical Indicators
RSI(14)
Neutral 46.96
ATR(14)
Less Volatile 12.09
STOCH(9,6)
Neutral 41.67
STOCH RSI(14)
Neutral 73.06
MACD(12,26)
Bullish 0.42
ADX(14)
Weak Trend 24.62
UO(9)
Bearish 48.47
ROC(12)
Uptrend And Accelerating 4.60
WillR(14)
Neutral -43.27
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
